|
Symbol
|
OSLRCH | RMBQ5V | KZEHDU | KZJVDU | RMBAIV | Z0AK9Z | Z0AKAZ | PLSRCH | ABYHTQ | ACGJTQ | BGLBIL | PUIRCH | KZXVDU | RMAXAV | Z0AXYZ | LAAHDU | Z0B18Z | RMA09V | RMBX5V | ACMVSQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Worst of Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible |
|
Sous-jacent
|
Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | NextEra Energy Inc. / Novo Nordisk AS (B) / Reckitt Benckiser Group Plc. | NextEra Energy Inc. / Novo Nordisk AS (B) / Reckitt Benckiser Group Plc. | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS | Moderna Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | ASML Hldg. N.V. / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS | Amazon.com Inc. / Novo Nordisk AS (B) / UBS Group AG | Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Novo Nordisk AS (B) / SAP SE | Eli Lilly & Co. / Novo Nordisk AS (B) |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
19.08.2026 | 17.11.2026 | 20.11.2026 | 30.12.2026 | 30.12.2026 | 13.07.2026 | 13.07.2026 | 13.07.2026 | 21.07.2026 | 03.09.2026 | 28.08.2026 | 17.09.2026 | 08.09.2026 | 12.10.2026 | 16.10.2026 | 28.10.2026 | 29.10.2026 | 12.05.2027 | 16.11.2026 | 23.11.2026 |
| Demande | 36,800 | 46,110 | 45,750 | 43,500 | 56,59 | - | - | 52,48 | 58,92 | 52,04 | 75,44 | 55,71 | 51,60 | 78,05 | - | 78,95 | - | 69,37 | 57,19 | 80,24 |
| Offre | - | - | 46,750 | - | - | - | - | - | - | - | - | - | 52,60 | - | - | 79,95 | - | - | - | - |